With the realignment of its Research & Development as well as through the formation of a high-ranking staffed Scientific Advisory Board, Oerlikon Textile GmbH & Co is strengthening its innovative capabilities.
Credit Suisse expects nanotechnology to make a breakthrough in the near future. Many new materials, applications and services currently under development are likely to emerge in the next decade and revolutionize everyday life. Therefore, Credit Suisse has developed the Credit Suisse Global Nanotechnology Index, which focuses on companies offering nanotechnology products.
FUJIFILM Dimatix, Inc., today announced its collaboration with Agilent Technologies Inc., to supply Agilent with innovative inkjet products based on the latest semiconductor manufacturing technologies for use in life sciences applications.
GenISys GmbH, a provider of e-beam direct write software solutions, today announced that three more U.S. research institutions have adopted its advanced e-beam lithography software. These world-class R&D centers' purchase decisions help to secure GenISys' leading market position and to establish a new standard in this emerging technology area.
Swagelok was just one of many businesses exhibiting at the third annual NanoFocus state conference at the Cox Center in downtown Oklahoma City. The event, sponsored by the Oklahoma NanoTechnology Initiative and the state Experimental Program to Stimulate Competitive Research, will conclude today.
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which anticipates that there will be a boom between 2010 and 2015 in the nanobiotechnology market.
Voxtel, Inc. plans to announce its entry into the business of manufacturing 'green' semiconductor and metal-oxide nanocrystals for a wide variety customer applications, including: photovoltaic solar cells, electro-luminescent lighting, anti-counterfeiting taggants, and security inks.
Hill-Rom and NanoHorizons, Inc. today announced an agreement to incorporate NanoHorizon's antimicrobial technology into Hill-Rom's patient support surfaces. This technology, to be branded as 'nanoAg+ with SmartSilver', will bring new levels of protection against institutionally-borne pathogens.
NanoBio Corporation has received its third $10 million tranche of equity funding from Perseus LLC, after having successfully met three critical development milestones: validating the efficacy and safety of its two topical treatments for skin infections and demonstrating the strength of its influenza vaccine in ferret studies.
PrimeGen Biotech LLC and Unidym Inc., a majority-owned subsidiary of Arrowhead Research Corporation, announced a corporate alliance focused on exploring new applications for carbon nanotubes in stem cell medicine.
Arrowhead Research Corporation announced today that Dr. Christopher Anzalone, Arrowhead's Chief Executive Officer and President, will present the Company's strategic plan and objectives for 2008 at 10:30 am PT on March 13, 2008, following the scheduled Annual Meeting of Shareholders.
Altair Nanotechnologies Inc. announces that it will hold a conference call to discuss financial results for the year ended Dec. 31, 2007. The call, scheduled for March 12, 2008 at 11:00 a.m. Eastern Standard Time (EST).
GE announced it is ramping up its efforts to enable global electrification of transportation by investing in Norwegian electric car manufacturer Think, which unveiled a five-seat crossover concept car in Geneva today. To power its vehicles, Think has signed a commercial supply agreement with lithium-ion battery manufacturer A123Systems. GE is in a unique position to help both companies commercialize technology to make electric transportation practical and affordable.
MFIC Corporation announced today that it expects to release fourth quarter 2007 and year end results on Wednesday, March 12, 2008, before the opening of the U.S. financial markets. A conference call will be held at 8:30 AM Eastern Time on Wednesday, March 12, 2008 to review the financial results and to outline key 2008 strategic initiatives.
On March 12, the MIT Enterprise Forum of Cambridge will feature a keynote address by Dr. George Whitesides, life sciences pioneer, successful entrepreneur and currently the Woodford L. and Ann A. Flowers University Professor at Harvard University. Dr. Whitesides' presentation will be followed by a panel discussion with experts in life sciences, focusing on the challenges of collaborating on product development and commercializing technology.